Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: How strong is the evidence? [9]

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 8, 2006, Pages 1283-1285

  Yuan, Y ^a   Thabane, L ^a   Hunt, R H ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; META ANALYSIS; PRIORITY JOURNAL; RISK; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNCERTAINTY; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OFLOXACIN; TREATMENT FAILURE;

EID: 33646866772     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02857.x     Document Type: Letter

References (4)

1. Gisbert JP Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006 23 : 35 44.
2. Moayyedi P. Meta-analysis: can we mix apples and oranges Am J Gastroenterol 2004 99 : 2297 301.
3. Whitehead A. Meta-Analysis of Controlled Clinical Trials. New York, NY : Wiley, 2002 : 157 64
4. S Peto R Lewis J Collins R Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985 27 : 335 7.